Background: In a number of human malignancies, the presence of lymphocytic infiltration in
or around tumor tissue is commonly considered to be part of the host tumor immune …

Immune responses against thyroid carcinomas have long been demonstrated and
associations between inflammatory microenvironment and thyroid carcinomas repeatedly …

Objective: Screening prognostic related genes of thyroid papillary carcinoma (PTC) by
single-cell RNA sequencing (scRNA-seq). To construct the diagnostic and prognostic …

Increasing evidence has indicated a close association between immune infiltration in cancer
and clinical outcomes. However, related research in thyroid cancer is still deficient. Our …

Background Although well-differentiated papillary thyroid cancer may remain indolent,
lymph node metastases and the recurrence rates are approximately 50% and 20 …

Thyroid cancer is the most prevalent endocrine malignancy that comprises mostly indolent
differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or …

Background: Advanced thyroid cancers, including differentiated thyroid carcinoma (DTC)
with distant metastasis, and anaplastic thyroid carcinoma (ATC), are associated with poor …

There has been an increase in the mortality rate of thyroid cancer (THCA), which is the most
common endocrine malignancy. We identified six distinct cell types in the THAC …

Background/objective There is an increasing rate of papillary thyroid carcinomas that may
never progress to cause symptoms or death. Predicting outcome and determining tumour …

Papillary thyroid carcinoma (PTC) represents a heterogeneous disease with diverse clinical
outcomes highlighting a need to identify robust biomarkers with clinical relevance. We …